SIMEDHealth Joins Innovo Research Network for Clinical Trials

GAINESVILLE, Fla., Oct. 15, 2026 /CourierPR/ -- Gainesville-based multispecialty group SIMEDHealth has joined the Innovo Research Network, a site management organization that embeds clinical research operations within independent community physician groups. The partnership gives sponsors and contract research organizations (CROs) single-contract access to SIMEDHealth’s physicians and patients, and provides North Central Florida residents more opportunities to participate in clinical trials close to home. SIMEDHealth, founded in 1987, is a physician-owned, integrated multispecialty group with clinical campuses in Gainesville, Ocala, Chiefland, High Springs, Lady Lake/The Villages, and Lake City. Its more than 90 physicians and advanced health providers provide care for over 60,000 unique patients across primary care, allergy and asthma, neurology, podiatry, pulmonology, rehabilitation medicine, rheumatology, interventional pain management, urology, women's health, hand surgery, sleep medicine, and other specialties.

SIMEDHealth Research brings an established track record to the network, with more than 150 completed clinical trials. Its current and planned work spans respiratory disease, vaccines, infectious disease, gout, weight loss, diabetes, chronic pain, arthritis, and cancer screening. On-site imaging, laboratory, sleep center, and physical therapy services support efficient study visits within the practice. As an Innovo partner, SIMEDHealth will gain centralized support for study start-up, regulatory, contracting, and budgeting, patient recruitment, quality and training, and data-driven patient identification. Research stays embedded in SIMEDHealth’s clinics, so patients can explore trial participation as part of their regular care.

SIMEDHealth joins a network of independent community physician groups across the United States, including Christie Clinic, Piedmont Healthcare, Wilmington Health, The Iowa Clinic, and Austin Regional Clinic. Together, Innovo's partner sites reach approximately 6.5 million patients and are conducting more than 150 studies across nearly every therapeutic area.

The Innovo Research Network, founded in 2010, is a site management organization that embeds clinical research operations within leading independent community physician groups. Through a single contract, single IRB, and centralized budget, Innovo gives sponsors and CROs streamlined access to a national network of physician-led sites reaching approximately 6.5 million patients. Innovo provides each partner with central study start-up, regulatory, quality, training, recruitment, and financial support, so physicians can offer research as part of everyday care.